Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inpatient antibiotic resistance: Everyone's problem.

Dora E Wiskirchen1,2, Ulysses Wu3,4, Maria Summa1,5

  • 1Department of Pharmacy Practice and Administration, School of Pharmacy, University of Saint Joseph, Hartford, CT, USA.

The Journal of Family Practice
|February 6, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Polypharmacology-Driven Approach to Alzheimer's Disease and Tauopathies: Rational Design, Synthesis and Characterization of Amino-Pyrazole-Based Multikinase (GSK-3β/FYN-α/DYRK1A) Inhibitors.

Journal of medicinal chemistry·2026
Same author

Red Blood Cell Exchange Transfusion for Severe Babesiosis.

JAMA internal medicine·2026
Same author

Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025
Same author

CDC42-effector interaction inhibitors alter patterns of vessel arborization in skin and tumors <i>in vivo</i>.

iScience·2025
Same author

Active Biopaste for Coral Reef Restoration.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Resmetirom (Rezdiffra) for the Treatment of Noncirrhotic Nonalcoholic Steatohepatitis With Moderate to Advanced Fibrosis.

American family physician·2024

Antimicrobial resistance requires careful antimicrobial use and new drug development. Family physicians can reduce resistance by implementing antimicrobial stewardship in inpatient settings.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Family Medicine

Background:

  • Antimicrobial resistance (AMR) poses a significant global health threat.
  • The emergence of multidrug-resistant (MDR) pathogens necessitates urgent action.
  • Appropriate antimicrobial use is crucial for combating AMR.

Purpose of the Study:

  • To outline evidence-based management strategies for inpatient infections caused by resistant bacteria.
  • To highlight the role of family physicians in antimicrobial stewardship.
  • To emphasize methods for reducing the further development of antimicrobial resistance.

Main Methods:

  • Review of current literature on managing resistant bacterial infections in hospitals.
  • Analysis of antimicrobial stewardship principles and practices.

Related Experiment Videos

  • Discussion of the family physician's contribution to infection control and AMR reduction.

    • Main Results:

    • Effective management of inpatient resistant infections relies on judicious antimicrobial selection and duration.
    • Antimicrobial stewardship programs are essential for optimizing patient outcomes and conserving antibiotic effectiveness.
    • Family physicians are integral to implementing stewardship by prescribing appropriately and educating patients.

    Conclusions:

    • Coordinated efforts in antimicrobial use and new drug discovery are vital to address AMR.
    • Evidence-based management and robust antimicrobial stewardship are key to controlling resistant infections.
    • Family physicians play a critical role in mitigating the spread of antimicrobial resistance.